Abstract
Myelodysplastic syndromes (MDS)are a heterogeneous group of clonal hematopoietic disorders that display ineffective hematopoiesis. About a third of patients with MDS progress to AML. The microenvironment contributes to the regulation of self-renewal, maintenance, differentiation, proliferation and apoptosis of progenitor cells and when is abnormal can favor diseases development. Previous…